Arama Sonuçları

Listeleniyor 1 - 6 / 6
  • Yayın
    Imagined contact facilitates acculturation, sometimes: contradicting evidence from two sociocultural contexts
    (Educational Publishing Foundation-American Psychological Assoc, 2019-10) Bağcı Hemşinlioğlu, Sabahat Çiğdem; Piyale, Zeynep Ecem; Stathi, Sofia
    Objective: Imagined intergroup contact has been shown to be an effective tool to improve intergroup relationships in various settings, yet the application of the strategy among minority group members and across cultures has been scarce. The current research aimed to test imagined contact effects on minority group members' acculturation strategies (contact participation and culture maintenance), perceived discrimination, feelings of belongingness, and social acceptance across three studies conducted in the United Kingdom (Study 1) and Turkey (Studies 2 and 3). Method: The sample consisted of Eastern Europeans in Study 1 (N = 63) and Kurds in Study 2 and 3 (N = 66 and 210, respectively). Participants were randomly assigned to 1 of 2 conditions (control vs. imagined contact) and completed measures of acculturation, perceived discrimination, general belongingness, and social acceptance. Results: Findings showed that while imagined contact significantly reduced perceived discrimination and culture maintenance, and increased contact participation and social acceptance among Eastern Europeans (Study 1), it reduced social acceptance and contact participation among Kurds recruited from a conflict-ridden homogeneous setting (Study 2). With a larger and more heterogeneous sample of Kurds (Study 3), these effects occurred only among those with higher ingroup identification. Moreover, in all studies social acceptance mediated the effects of imagined contact on contact participation and perceived discrimination. Discussion. Findings offer important insights about the use of the imagined contact strategy among minority group members and imply the need to take into account the context-dependent nature of contact strategies.
  • Yayın
    Pedestrian crossing behavior at midblock crosswalks
    (Elsevier Ltd, 2019-12) Tezcan, Hüseyin Onur; Elmorssy, Mahmoud; Aksoy, Göker
    Introduction: This study investigated the pedestrian crossing behavior at midblock crosswalks, in Istanbul. Method: Data were compiled from field studies at four selected crosswalks that were on one-way streets. Three of the crosswalks were located on three-lane streets while the other one was on a two-lane street. By using two-hour video recordings at each crosswalk, information was collected about pedestrian crossing preferences, pedestrian platoons both at curbside and during the crossing, traffic characteristics including volume, crosswalk occupancy and illegal parking, and pedestrian characteristics comprising age, gender and distraction status. These data were stratified with respect to the number of lanes and two multinomial logit models for platooning and individual crossing behavior was estimated for each stratum. Results: The results showed that the likelihood of platooning increases as the traffic volume and platoon size increase. Moreover, pedestrians who waited for little or no at the curbside and started to cross when one or more lanes were occupied generally lost time during the crossing. In terms of policy, the formation of platoons should be prevented by enforcement or demand-responsive traffic signals with push-to-walk buttons, etc. Overall, the study revealed that the presence of midblock crosswalks is questionable.
  • Yayın
    Cross-group friendships and psychological well-being: A dual pathway through social integration and empowerment
    (Wiley, 2018-10-01) Bağcı Hemşinlioğlu, Sabahat Çiğdem; Türnüklü, Abbas; Bekmezci, Eyüp
    This study investigated the associations between cross-group friendships and psychological well-being among a sample of physically disabled adults. A total of 269 disabled people (M-age=39.13, SD=13.80; 114 females, 152 males, 3 unknown) completed questionnaires including the quality of their friendships with non-disabled people, perceived majority group's attitudes towards the minority group, collective self-esteem, collective action tendencies, own outgroup attitudes, and psychological well-being. Findings demonstrated that disabled people's cross-group friendships were directly and indirectly associated with higher levels of psychological well-being via two routes: one by promoting perceived majority attitudes which consequently led to more positive own outgroup attitudes (well-being through social integration hypothesis) and the other by leading to higher levels of collective self-esteem which enhanced collective action tendencies (well-being through empowerment hypothesis). Findings offer important insights into the study of cross-group friendships in relation to the psychological well-being of stigmatized minority group members.
  • Yayın
    Associations between cerebral perfusion pressure, hemodynamic parameters, and cognitive test values in normal-tension glaucoma patients, Alzheimer’s disease patients, and healthy controls
    (Multidisciplinary Digital Publishing Institute (MDPI), 2025-05-24) Stoskuviene, Akvile; Chaleckas, Edvinas; Grusauskiene, Evelina; Bartusis, Laimonas; Çelikkaya, Güven; Januleviciene, Ingrida; Vaitkus, Antanas; Ragauskas, Arminas; Hamarat, Yasin
    Background/Objectives: Glaucoma and Alzheimer’s disease (AD) are neurodegenerative conditions with vascular underpinnings. This study aimed to explore the relationship between blood pressure parameters such as mean arterial pressure (MAP), pulse pressure (PP), and cerebral perfusion pressure (CPP) and cognitive performance in patients with AD, normal-tension glaucoma (NTG), and healthy controls. We hypothesized that NTG patients, like those with mild cognitive impairment (MCI), may experience subtle cognitive changes related to vascular dysregulation. Methods: Ninety-eight participants (35 NTG, 17 AD, 46 controls) were assessed for CPP, MAP, OPP, and cognitive performance. Statistical analyses compared groups and examined correlations. Results: AD patients showed lower CPP and MAP (p < 0.001), indicating systemic vascular dysfunction, while NTG patients had higher ocular perfusion pressure (OPP) (p = 0.008), suggesting compensatory mechanisms. CPP correlated with visuospatial abilities in AD (r = 0.492, p = 0.045). MAP correlated with the Clock drawing test (CDT) scores in the NTG group (r = 0.378, p = 0.025). PP negatively correlated with cognition in AD (r = −0.527, p = 0.016 for CDT scores) and controls (r = −0.440, p = 0.002 for verbal fluency and r = −0.348, p = 0.019 for total ACE scores). Conclusions: The study highlights distinct hemodynamic profiles: systemic dysfunction in AD and localized dysregulation in NTG. These findings emphasize the role of vascular dysregulation in neurodegeneration, with implications for personalized treatment approaches targeting vascular health in neurodegenerative conditions.
  • Yayın
    Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries
    (Elsevier Ireland Ltd, 2025-06) Fountoulakis, Konstantinos N.; Karakatsoulis, Gregory; Abraham, Seri; Adorjan, Kristina; Uddin Ahmed, Helal; Alarcòn, Renato Daniel; Arai, Kiyomi; Auwal, Sani Salihu; Berk, Michael; Levaj, Sarah; Yılmaz Kafalı, Helin
    Introduction: This study registered rates of specific treatment options for mental disorders as well as their long-term outcome. Material and methods: The history of mental disorders was used as a proxy for diagnosis. The data came from the COMET-G study (40 countries; 54,826 subjects, 64.73 % females, 35.45±13.51 years old). The analysis included descriptive statistics, Risk Ratios, t-tests, and ANCOVA's. Results: 24.14 % reported a history of any mental disorder (depression >12 %, non-affective psychosis and Bipolar disorder 1 % each, >20 % self-injury, >10 % had attempted suicide, 7.17 % illegal substance abuse). Most patients were not under any kind of treatment (59.44 %) and most were not receiving treatment as recommended (e.g. 90 % of Bipolar and 2/3 of psychotic patients). No treatment at all and psychotherapy as monotherapy were consistently related to poorer outcomes. In anxiety or depression, only antidepressant monotherapy and benzodiazepines, in Bipolar disorder only antipsychotic monotherapy in males and antidepressant monotherapy in females and in non-affective psychosis antipsychotics and psychotherapy in females only, were related to good outcomes. No treatment modality was related to a good outcome in those with a history of self-harm, suicidal attempts, or illegal substance use. Only depression and treatment with antidepressants were related to metabolic syndrome. Discussion: In the community, the overwhelming majority of mental patients do not receive appropriate treatment or, even worse, no treatment at all. The outcome is unfavourable for the majority and only a few selective treatment options seem to make a difference.
  • Yayın
    Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis
    (Elsevier B.V., 2025-12) Højlund, Mikkel; Yılmaz Kafalı, Helin; Kırmızı, Begüm; Fusar-Poli, Paolo; Correll, Christoph U.; Cortese, Samuele; Sabé, Michel; Fiedorowicz, Jess; Saraf, Gayatri; Zein, Josephine; Berk, Michael; Husain, Muhammad I.; Rosenblat, Joshua D.; Rubaiyat, Ruby; Corace, Kim; Wong, Stanley; Hatcher, Simon; Kaluzienski, Mark; Yatham, Lakshmi N.; Cipriani, Andrea; Gosling, Corentin J.; Carhart-Harris, Robin; Tanuseputro, Peter; Myran, Daniel T.; Fabiano, Nicholas; Moher, David; Mayo, Leah M.; Nicholls, Stuart G.; White, Tracy; Prisco, Michele De; Radua, Joaquim; Vieta, Eduard; Ladha, Karim S.; Katz, Jay; Veroniki, Areti A.; Solmi, Marco
    Serotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a continuously evolving evidence base. We searched Pubmed/Scopus/clinical trial registries up to 08july2025 for double-blind randomized controlled trials (RCTs) testing MDMA or serotonergic psychedelics in patients with mental disorders. Primary outcomes were change in disease-specific symptoms and all-cause discontinuation. Standardized mean differences (SMD) and relative risk (RR) were estimated using random-effects meta-analysis. Risk of bias (RoB) was assessed with Cochrane’s RoB-tool version 2 and certainty of evidence with GRADE. The review is maintained as living systematic review ( https://ebipsyche-database.org/ ). We included 30 RCTs (1480 participants; female=45.8 %; with psychological support=83.3 %; high RoB=83.3 %). In post-traumatic stress disorder (PTSD), MDMA reduced PTSD symptoms compared to any control ( k = 11; SMD=-0.85 [-1.09; -0.60]; I2=0 %; GRADE=low). In major depressive disorder (MDD), psilocybin/ayahuasca/LSD reduced depressive symptoms ( k = 8; SMD=-0.62 [-0.97; -0.28]; I2=55 %; GRADE=very low). In anxiety disorders, both MDMA and serotonergic psychedelics reduced anxiety symptoms (SMDMDMA=-1.18 [-2.04; -0.32]; I2=0 %; k = 2; GRADE=low and SMDserotonergic=-0.88 [-1.70; -0.06]; I2=54 %; k = 5; GRADE=very low). In alcohol use disorder, neither psilocybin nor LSD reduced abstinence rates ( k = 6; RR=1.42 [0.89; 2.26]; I2=7 %; GRADE=very low). In attention-deficit hyperactivity disorder (ADHD), LSD did not reduce ADHD symptoms ( k = 1; SMD=0.22 [-0.32; 0.76]; GRADE=very low). Moderate certainty in evidence was only found for MDMA on PTSD symptoms when compared to placebo. MDMA/serotonergic psychedelics were not associated with higher risk of all-cause discontinuation (RRMDMA=0.74 [0.32; 1.72]; RRserotonergic=0.81 [0.56; 1.15]). Overall, MDMA/serotonergic psychedelics are promising for the treatment of PTSD, MDD, and anxiety disorders with moderate to large effect sizes. Pragmatic trials, long-term, head-to-head trials exploring the role of psychological support, aiming to identify predictors of response, and accounting for expectancy and functional unblinding are needed. Studies addressing these limitations will likely be required for regulatory approval of psychedelic drugs.